Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong · Delayed Price · Currency is HKD 190.00
-31.20 (-14.10%)
Jul 30, 2026, 2:15 PM HKT
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 20 billion as of July 29, 2026. Its market cap has decreased by -33.17% in one year.
Market Cap
20.00B
Enterprise Value
16.41B
Revenue
2.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
190.00
ChartMarket Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has increased from 17.51B to 20.00B, an increase of 14.21%. That is a compound annual growth rate of 10.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 20.60B | -22.74% |
| Dec 31, 2025 | 26.66B | 52.24% |
| Apr 15, 2025 | 17.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Junshi Biosciences | 38.01B |
| Genscript Biotech | 36.81B |
| Shanghai Henlius Biotech | 30.44B |
| InnoCare Pharma | 28.47B |
| Keymed Biosciences | 24.25B |
| Zai Lab | 16.42B |
| Ascentage Pharma Group International | 13.23B |
| Metis TechBio | 12.97B |